Cross-cohort validation of EEG biomarkers using a pre-registered three-criterion framework: a demonstration in amyotrophic lateral sclerosis
Background. Despite decades of EEG biomarker development for amyotrophic lateral sclerosis (ALS), no candidate has progressed to clinical deployment, partl